RecruitingNCT07261865

Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients

Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients and Assessing Their Impact on Organ Failure and Outcome.


Sponsor

University Medical Center Groningen

Enrollment

4,395 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

In the Netherlands, patients admitted to the ICU are classified as having diabetes based on whether their medical records indicate glucose management medication use (Dutch National Intensive Care Evaluation (NICE) Registry). However, this approach does not identify patients with 1) undiagnosed diabetes, 2) uncontrolled diabetes, 3) patients managing their condition through lifestyle modifications, or 4) individuals with prediabetes, which is considered an early stage of diabetes. Consequently, this may lead to an underestimation of the "true" prevalence of chronic dysglycaemia among ICU patients and as a result the impact of various glycaemic states on acute outcomes remain underexplored.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All adult patients admitted to the ICU

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Frisius MC

Leeuwarden, Provincie Friesland, Netherlands

University Medical Center Groningen

Groningen, Provincie Groningen, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07261865


Related Trials